Skip to main content

Sobi — Deal History & Benchmarks

Total Deals
2
Across 2 therapeutic areas
Total Deal Value
$4.1B
Cumulative transaction value
Most Active Year
2023
2 deals closed
Primary TA
Hematology
50% of deal activity
Model Your Deal

Market Analysis

Sobi has been involved in 2 transactions totaling $4.1B across Hematology, Rare Disease. As both a licensor and licensee, they have demonstrated an active acquisition strategy.

Key transactions include Swedish Orphan Biovitrum (Sobi) ($2.4B, 2023), CTI BioPharma ($1.7B, 2023).

Their deal activity is concentrated in Hematology (50%) with Small Molecule and Monoclonal Antibody assets representing their most common deal types.

PRO

Full Benchmark Analysis

Complete deal term ranges, comparable transactions, and negotiation insights.

Start 7-Day Free Trial

$299/mo after trial · Cancel anytime

Customize these benchmarks for your asset

Adjust phase, modality, competitive position, and 10+ other parameters.

Open Calculator

Frequently Asked Questions

How many deals has Sobi done?
Sobi has completed 2 verified transactions tracked in our database, spanning from 2023 to 2023. These deals have a combined value of $4.1B.
What is Sobi's typical deal structure?
Sobi's most common deal type is acquisition, reflecting an active acquisition strategy. Specific upfront payment data is limited in publicly disclosed terms.
What therapeutic areas does Sobi focus on?
Sobi is primarily active in Hematology (50%), Rare Disease (50%).
PRO

Full Benchmark Analysis

Complete deal term ranges, comparable transactions, and negotiation insights.

Start 7-Day Free Trial

$299/mo after trial · Cancel anytime

Related Benchmarks

Hematology Deal Benchmarks

View

Small Molecule Deals

View

Rare Disease Licensing Benchmarks

View

Phase 2 Deal Benchmarks

View

Ready to Calculate Your Deal Terms?

Get instant, customized benchmarks based on real market data from 1,600+ biopharma licensing deals.

Start Calculating
For Funds & Advisors

Need the full deal landscape?

The Deal Intelligence Brief covers every modality and deal structure for this indication — 52 deal calculations, AI strategic narrative, comparable transactions, partner matching, and white-label branding. Delivered in 24 hours.

Configure Brief — $2,500All-inclusive · White-label · Walkthrough included